In the past month, shares of INO have skyrocketed 134.2% compared with the industry’s 6.5% rise. The significant uptick in the stock price was observed after the company announced plans to ...

Shares of Inovio Pharmaceuticals Inc. INO inched 0.36% higher to $5.54 Friday, on what proved to be an all-around favorable ...

And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on INO going forward to see if this recent jump can ...

Shares of Inovio Pharmaceuticals Inc. INO slipped 1.94% to $5.56 Tuesday, on what proved to be an all-around mixed trading ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest in Inovio Pharmaceuticals Inc (NASDAQ:INO) increased during the last reporting ... on the decline of Inovio Pharmaceuticals's stock. Short interest data is updated every two weeks.

Innovio announced the presentation of new data at scientific conferences for its lead candidate, INO-3107, for which the company is preparing a Biologics License Application for targeted ...

This comprehensive analysis examines the company's current position, future prospects, and the factors influencing its stock performance. Inovio's flagship product, INO-3107, a therapy for recurrent ...